Molecular-Physiological Aspects of Regulatory Effect of Peptide Retinoprotectors
- 28 Downloads
Retinal diseases were always difficult problem for clinical ophthalmology. Modern methods of their treatment only decrease risk of complications, however in Russia was created better technology for this purpose: peptide bioregulators, which were made by sequential adding of amino acids one to another, binding with the promoter region of genes, and promoting retinoprotective effect by regulation of their expression, improving the state of the retina.
KeywordsShort peptides Peptide bioregulators DNA Retinal diseases Binding sites Promoter regions
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict ofinterest.
Informed consent was obtained from all individual participants included in the study.
Statement of Human Rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Statement on the Welfare of Animals
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
- 6.Afarid, M., Sarvestani, A. S., Rahat, F., & Azimi, A. (2018). Intravitreal injection of bevacizumab: Review of our previous experience. Iranian Journal of Pharmaceutical Research: IJPR, 17(3), 1093–1098.Google Scholar
- 7.Cislo-Pakuluk, A., & Marycz, K. (2017). A promising tool in retina regeneration: Current perspectives and challenges when using mesenchymal progenitor stem cells in veterinary and human ophthalmological applications. Stem Cell Reviews and Reports, 13(5), 598–602. https://doi.org/10.1007/s12015-017-9750-4.CrossRefGoogle Scholar
- 8.Bennis, A., Jacobs, J. G., Catsburg, L. A. E., ten Brink, J. B., Koster, C., Schlingemann, R. O., van Meurs, J., Gorgels, T. G. M. F., Moerland, P. D., Heine, V. M., & Bergen, A. A. (2017). Stem cell derived retinal pigment epithelium: The role of pigmentation as maturation marker and gene expression profile comparison with human endogenous retinal pigment epithelium. Stem Cell Reviews and Reports, 13(5), 659–669. https://doi.org/10.1007/s12015-017-9754-0.CrossRefGoogle Scholar
- 9.Siqueira, R. C., Messias, A., Messias, K., Arcieri, R. S., Ruiz, M. A., Souza, N. F., Martins, L. C., & Jorge, R. (2015). Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (reticell -clinical trial). Stem Cell Research & Therapy, 6(1), 29–34. https://doi.org/10.1186/s13287-015-0020-6.CrossRefGoogle Scholar
- 10.Swoboda, J. G., Elliott, J., Deshmukh, V., de Lichtervelde, L., Shen, W., Tremblay, M. S., Peters, E. C., Cho, C. Y., Lu, B., Girman, S., Wang, S., & Schultz, P. G. (2013). Small molecule mediated proliferation of primary retinal pigment epithelial cells. ACS Chemical Biology, 8(7), 1407–1411. https://doi.org/10.1021/cb4001712.CrossRefGoogle Scholar
- 13.Khavinson, V. K., Pronyaeva, V. E., Linkova, N. S., & Trofimova, S. V. (2013). Peptidergic regulation of differentiation of embrionic cells. Cell Technologies in Biology and Medicine, 1, 172–175.Google Scholar
- 14.Khavinson, V. K. (2002). Peptides and aging. Neuroendocrinology Letters, 23(Suppl. 3, Special Issue).Google Scholar
- 15.Khavinson V. Kh. (2001). Tetrapeptide, stimulating functional activity of the retina, pharmacological substance on its basis, and the method of its application. Patent of the Russian Federation No. 2161982.Google Scholar
- 19.Khavinson, V. K., Razumovsky, M., Trofimova, S., et al. (2002). Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa. Neuroendocrinology Letters, 23(4), 365–368.Google Scholar
- 20.Caputi S., Trubiani O., Bruna S., Trofimova S. (2018). Short peptides regulate proliferation and neuronal differentation of stem cells. In: Book of abstracts international symposium of experts «effective current approaches in anti-aging medicine and gerontology», Sweden, 13–14 April, 2018, pp. 24–26.Google Scholar
- 23.Khavinson, V. K., Pronyaeva, V. E., Linkova, N. S., Trofimova, S. V., & Umnov, R. S. (2014). Molecular-physiological aspects of peptide regulation of the function of the retina in retinitis pigmentosa. Human Physiology, 40(1), 129–134. https://doi.org/10.1134/S036211971401006X.CrossRefGoogle Scholar
- 25.Fedoreyeva, L. I., Kireev, I. I., Khavinson, V. K., & Vanyushin, B. F. (2011). Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry, 76(11), 1210–1219. https://doi.org/10.1134/S000629791111022.Google Scholar
- 28.Khavinson, V. K., Linkova, N. S., Pronyaeva, V. E., Chalisova, N. I., Koncevaya, E. A., Polyakova, V. O., Kvetnaya, T. V., Kvetnoy, I. M., & Yakovlev, G. M. (2012). A method of creating a cell monolayer based on organotypic culture for screening of physiologically active substances. Bulletin of Experimental Biology and Medicine, 2, 759–763. https://doi.org/10.1007/s10517-012-1829-y.Google Scholar
- 29.Khavinson, V. K., Tarnovskaya, S. I., Linkova, N. S., Pronyaeva, V. E., Shataeva, L. K., & Yakutseni, P. P. (2012). Short cell-penetrating peptides: A model of interactions with gene promoter sites. Bulletin of Experimental Biology and Medicine, 154(9), 391–396. https://doi.org/10.1007/s10517-013-1961-3.Google Scholar
- 30.Datseris Y., Diamanti R., Trofimova S. (2016). Results of many years of application of peptide bioregulators in patients with retinitis pigmentosa. In: Book of Abstracts. Proceedings of V European Congress of Preventive, Regenerative and Anti-Aging Medicine, Saint Petersburg. September 8–10, 2016. Saint Petersburg: FlyPrint., pp.31–32.Google Scholar
- 31.Datseris Y., Diamanti R., Trofimova S. (2018). Retinoprotective effect of peptide bioregulators in treatment of retinitis pigmentosa. In: Book of Abstracts International Symposium of Experts «Effective Current Approaches in Anti-Aging Medicine and Gerontology», Sweden, 13–14 April, 2018, pp.30–33.Google Scholar
- 32.Khavinson V. Kh., Malinin V. V. (2005). Gerontological aspects of genom peptide regulation. Basel (Switzerland): Karger AG. https://doi.org/10.1007/s10541-005-0245-6.